EUCTR2008-001308-22-NL进行中（未招募）不适用
Aspirin sensitivity in diabetes mellitus; the role of glycaemic control and dosing - ASSIG
Academic Medical Centre0 个研究点开始时间: 2008年3月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age > 18 years
- •Diagnosis of type 2 diabetes according to ADA criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Current acetylsalicylic acid therapy
- •Use of any medication interfering with platelet function, e.g. diclofenac, naproxen or clopidogrel in the two weeks prior to the study.
- •Abnormal platelet count
- •Allergy or hypersensitivity to prostaglandinsynthetase inhibitors
- •Hemorrhagic stroke in medical history
- •Gastric complaints or gastritis/ulcus pepticum, history of gastric bleeding
- •Severe liver or kidneyfailure
研究者
相似试验
尚未招募
4 期
Aspirin sensitivity in diabetes mellitus; the role of glycaemic control and dosingdiabetes mellitusNL-OMON31925Academisch Medisch Centrum140
尚未招募
不适用
Aspirin sensitivity in diabetes mellitus; the role of glycaemic control and dosingNL-OMON26330Prof. dr. J.B.L. HoekstraDept. of Internal MedicineAcademic Medical Centre140
已完成
不适用
Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic PatientsDiabetes Mellitus, Type IINCT00649909Hadassah Medical Organization18
已完成
4 期
Aspirin Dosing in Diabetic PatientsType 2 Diabetes MellitusCoronary Artery DiseaseNCT01201785University of Florida20
Unknown
3 期
Aspirin and Renal Disease Progression in Patients With Type 2 DiabetesDiabetesNCT02895113University of Roma La Sapienza418